MRSA pneumonia: Better outcome through continuous infusion of vancomycin?

被引：18

作者：

Blot, S ^{[1
]}

机构：

[1] State Univ Ghent Hosp, Dept Intens Care, B-9000 Ghent, Belgium

来源：

CRITICAL CARE MEDICINE | 2005年 / 33卷 / 09期

关键词：

ventilator-associated pneumonia; methicillin-resistant Staphylococcus aureus; mortality; outcome; vancomycin; intensive care unit;

D O I：

10.1097/01.CCM.0000178288.70057.47

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：2127 / 2128

页数：2

共 15 条

[1] Early detection of systemic infections [J].

Blot, S ;

Vandewoude, K .

ACTA CLINICA BELGICA, 2004, 59 (01) :20-23

[2] Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus [J].

Blot, SI ;

Vandewoude, KH ;

Hoste, EA ;

Colardyn, FA .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2229-2235

[3] Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J].

Byl, B ;

Clevenbergh, P ;

Jacobs, F ;

Struelens, MJ ;

Zech, F ;

Kentos, A ;

Thys, JP .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :60-66

[4] Ventilator-associated pneumonia [J].

Chastre, J ;

Fagon, JY .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) :867-903

[5]

Cruciani M, 1996, J ANTIMICROB CHEMOTH, V38, P865

[6] Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock [J].

De Paepe, P ;

Belpaire, FM ;

Buylaert, WA .

CLINICAL PHARMACOKINETICS, 2002, 41 (14) :1135-1151

[7] Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection [J].

Di Filippo, A ;

De Gaudio, AR ;

Novelli, A ;

Paternostro, E ;

Pelagatti, C ;

Livi, P ;

Novelli, GP .

CHEMOTHERAPY, 1998, 44 (01) :63-68

[8] The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient [J].

Heyland, DK ;

Cook, DJ ;

Griffith, L ;

Keenan, SP ;

Brun-Buisson, C .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) :1249-1256

[9] THE IMPORTANCE OF PHARMACOKINETIC-PHARMACODYNAMIC SURROGATE MARKERS TO OUTCOME - FOCUS ON ANTIBACTERIAL AGENTS [J].

HYATT, JM ;

MCKINNON, PS ;

ZIMMER, GS ;

SCHENTAG, JJ .

CLINICAL PHARMACOKINETICS, 1995, 28 (02) :143-160

[10] Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections [J].

James, JK ;

Palmer, SM ;

Levine, DP ;

Rybak, MJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :696-700

← 1 2 →